Our Specials
Special Offer: 15.50 U$D Ea
Molecule Overview:
Paclitaxel is a cytotoxic antineoplastic agent classified as a taxane, it stabilizes microtubules and inhibits mitosis, leading to apoptotic cell death.
We have the following lote of Paclitaxel Available
Molecule Overview:
Paclitaxel is a cytotoxic antineoplastic agent classified as a taxane, it stabilizes microtubules and inhibits mitosis, leading to apoptotic cell death.
Primary Indications and Therapeutic Uses:
Paclitaxel is indicated in the treatment of multiple solid tumors, including:
Metastatic breast cancer (as monotherapy or in combination with anthracyclines)
Ovarian carcinoma (as first-line or salvage therapy)
Non-small cell lung cancer (NSCLC) (usually in combination with platinum agents)
Kaposi’s sarcoma in HIV-positive patients
Head and neck, pancreatic, bladder, and esophageal cancers (off-label or in combination protocols)
Available Presentations:
Most pharmaceutical manufacturers offer Paclitaxel in the following standardized sterile injectable formats:
- Paclitaxel Injection 30 mg/5 mL vial
- Paclitaxel Injection 100 mg/16.7 mL vial
- Paclitaxel Injection 260 mg/43.4 mL vial
- Nab-Paclitaxel (nanoparticle albumin-bound): 100 mg lyophilized powder (select manufacturers only)
